Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00556062
What this trial is testing

Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 566
Post-approval studies (Phase 4)Study completedNCT00192140
What this trial is testing

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

Who this might be right for
Influenza
MedImmune LLC 345
Not applicableUnknownNCT04110990
What this trial is testing

Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients

Who this might be right for
Influenza
University Hospital, Strasbourg, France 384
Early research (Phase 1)Study completedNCT02877160
What this trial is testing

Assess the PK of AL-794 Formulations in Healthy Subjects

Who this might be right for
Influenza
Alios Biopharma Inc. 31
Not applicableStudy completedNCT01408290
What this trial is testing

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 256
Large-scale testing (Phase 3)Study completedNCT05269290
What this trial is testing

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold
Valenta Pharm JSC 240
Large-scale testing (Phase 3)UnknownNCT03900988
What this trial is testing

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Who this might be right for
Influenza
Chinese University of Hong Kong 160
Post-approval studies (Phase 4)Study completedNCT01404182
What this trial is testing

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 121
Not applicableStudy completedNCT01979588
What this trial is testing

How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice

Who this might be right for
Influenza Like IllnessAsthmaGroup A Streptococcal Infection+1 more
Endeavor Health 206,703
Post-approval studies (Phase 4)Study completedNCT00389857
What this trial is testing

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 31
Post-approval studies (Phase 4)Study completedNCT00311428
What this trial is testing

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Who this might be right for
Influenza
Novartis 270
Not applicableStudy completedNCT06088563
What this trial is testing

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX

Who this might be right for
Vaccination; Infection
Centre Hospitalier Universitaire de Nice 38
Not applicableStudy completedNCT00296270
What this trial is testing

Memory for Flu Facts and Myths and Effects on Vaccine Intentions

Who this might be right for
Influenza Vaccines
University of Michigan 175
Not applicableStudy completedNCT01024673
What this trial is testing

Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)

Who this might be right for
Influenza
University of Pittsburgh 38
Large-scale testing (Phase 3)Study completedNCT03139565
What this trial is testing

High Dose vs. Standard Influenza Vaccine in Adult SOT

Who this might be right for
InfluenzaImmunosuppression
University Health Network, Toronto 172
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Not applicableStudy completedNCT01304563
What this trial is testing

2010/2011 Trivalent Influenza Vaccination

Who this might be right for
Influenza
The University of Hong Kong 240
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00316628
What this trial is testing

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Who this might be right for
Influenza
Novartis 50
Not applicableStudy completedNCT02401893
What this trial is testing

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

Who this might be right for
Aging
Vanderbilt University 510
Next Page